Author(s):
Agus Cahyono, Irwanto, Mahrus A Rahman, Widjiati Widjiati
Email(s):
irwanto@fk.unair.ac.id
DOI:
10.52711/0974-360X.2025.00638
Address:
Agus Cahyono1,2, Irwanto3*, Mahrus A Rahman3, Widjiati Widjiati4
1Doctoral Program of Medical Science, Faculty of Medicine, Airlangga University, Surabaya, Indonesia.
2Department of Clinical Medicine, Faculty of Medicine, Universitas Surabaya, Surabaya, Indonesia.
3Department of Child Health, Faculty of Medicine, Airlangga University, Surabaya, Indonesia.
4Department of Veterinary Science, Faculty of Veterinary Medicine, Airlangga University, Surabaya, Indonesia.
*Corresponding Author
Published In:
Volume - 18,
Issue - 9,
Year - 2025
ABSTRACT:
Pulmonary hypertension (PH) in children often underrecognized due to lack of awareness to its risk factors and diagnosis tool. In neonate population, these factors become more challenging. When diagnosis is made early, the treatment can be commenced earlier for better prognosis. The objective of this article is to report explorational study of pulmonary hypertension in neonates. Medical records of neonatal intensive care unit (NICU) patients for a year was reviewed. All NICU patients underwent echocardiography screening of PH within 48 hour from admission. Patients with PH were included in the study and the data was described for sex, bodyweight, gestational status, associated conditions and outcome. In a year, 167 patients was recorded admitting NICU with male predominance (96 male versus 71 female). Twenty patients with PH were identified with male and female ratio 1:1, and low birthweight and preterm infants predominance, (12 out of 20). Furthermore asphyxia, respiratory distress syndrome, transient tachypneu of the newborn, necrotizing enterocolitis, and systemic inflammatory response syndrome were associated with PH. Five patients died during nursery. Three representative PH patients revealed dilation of right atrium and tricuspid regurgitation on echocardiography examination. These patients were put on continuous positive airway pressure machine and received oral sildenafil 2mg/kg bodyweight. One of them died due to multiple organ dysfunction syndrome. Early echocardiography revealed pulmonary hypertension in neonates.
Cite this article:
Agus Cahyono, Irwanto, Mahrus A Rahman, Widjiati Widjiati. Pulmonary Hypertension in Neonates: Early identification and treatment. Research Journal of Pharmacy and Technology. 2025;18(9):4449-4. doi: 10.52711/0974-360X.2025.00638
Cite(Electronic):
Agus Cahyono, Irwanto, Mahrus A Rahman, Widjiati Widjiati. Pulmonary Hypertension in Neonates: Early identification and treatment. Research Journal of Pharmacy and Technology. 2025;18(9):4449-4. doi: 10.52711/0974-360X.2025.00638 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-9-58
REFERENCES:
1. Humbert M. Kovacs G. Hoeper MM. Badagliacca R. Berger RMF. Brida M. Calrsen J. Coats AJS. Escribano-Subias P. Ferrari P. Ferreira DS. Ghofrani HA. Giannakoulas G. Kiely DG. Mayer E. Meszaros G. Nagavci B. Olsson KM. Pepke-Zaba J. Quint JK. Radegran G. Simonneau G. Sitbon O. Tonia T. Toshner M. Vachiery JL. Noordegraaf AV. Delcroix M. Rosenkranz S. 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. European Heart Journal. 2023; 61: 2200879. doi: 10.1183/13993003.00879-2022
2. Hansmann G. Pulmonary hypertension in infants, children, and young adults. Journal of the American College of Cardiology. 2017; 69(20): 2551-2569. doi: 10.1016/j.jacc.2017.03.575.
3. Lakshminrusimha, S. Neonatal and postneonatal pulmonary hypertension. Children. 2021; 8(2): 131. doi: 10.3390/children8020131
4. Sharma V. Berkelhamer S. Laksminrusimha S. Persistent pulmonary hypertension of the newborn. Maternal Health Neonatology and Perinatology. 2015; 1: 14. doi: 10.1186/s40748-015-0015-4
5. Jone PN. Ivy DD. Echocardiography in pediatric pulmonary hypertension. Frontiers in Pediatrics. 2014; 2: 124. doi: 10.3389/fped.2014.00124
6. Kipfmueller F. Akkas S. Pugnaloni F. Bo B. Lemloh L. Schroeder L. Gembruch U. Geipel A. Berg C. Heydweiller A. Mueller A. Echocardiographic assessment of pulmonary hypertension in neonates with congenital diaphragmatic hernia using pulmonary artery flow characteristics. Journal of Clinical Medicine. 2022; 11(11): 3038. doi: 10.3390/jcm11113038.
7. Singh Y. Lakshminrusimha S. Pathophysiology and Management of Persistent Pulmonary Hypertension of the Newborn. Clinics in Perinatology. 2021; 48(3): 595–618. doi: 10.1016/j.clp.2021.05.009
8. Gorenflo M. Ziesenitz VC. Treatment of pulmonary arterial hypertension in children. Cardiovascular Diagnosis and Therapy. 2021; 11(4): 1144-1159. doi: 10.21037/cdt-20-912
9. Razzaq A. Quddusi AI. Nizami N. Risk factors and mortality among newborns with persistent pulmonary hypertension. Pakistan Journal of Medical Sciences. 2013; 29(5): 1099-1104. doi: 10.12669/pjms.295.3728
10. Thirumal BK. Nivetha R. Raja D. Radha S. Use of Doppler Echocardiography as a Prognostic Marker in Evaluating Hypertensive Patients with and without left Ventricular Hypertrophy – A Hospital Based Study in Vellore. Research Journal of Pharmacy and Technology. 2018; 11(9): 3983-3989. doi:10.5958/0974-360X.2018.00732.1
11. Delaney C. Cornfield DN. Risk factors for persistent pulmonary hypertension of the newborn. Pulmonary Circulation. 2012; 2(1): 15-20. doi: 10.4103/2045-8932.94818
12. Hernandez-Diaz S. Van Marter LJ. Werler MM. Louik C. Mitchell AA. Risk factors for persistent pulmonary hypertension of the newborn. Pediatrics. 2007; 120: e272-282. doi: 10.1542/peds.2006-3037
13. Mohsen AHA. Amin AS. Risk factors and outcomes of persistent pulmonary hypertension of the newborn in neonatal intensive care unit of Al-Minya University Hospital in Egypt. Journal of Clinical Neonatology. 2013; 2(2): 78-82. doi: 10.4103/2249-4847.116406.
14. Bilalova DF. Mindubayeva FA. Nigmatullina RR. Salikhova YY. Monocrotaline model of Pulmonary hypertension in immature rats from the perspective of Serotonergic regulation. Research Journal of Pharmacy and Technology. 2023; 16(8): 3915-3920. doi: 10.52711/0974-360X.2023.00644
15. Al-Najeem HT. Al-Dujaili ANG. Assessment of Gremlin-1 Level in Pulmonary arterial hypertension disease. Research Journal of Pharmacy and Technology. 2017; 10(11): 3803-3806. doi: 10.5958/0974-360X.2017.00690.4
16. Surendran HP. Louis DM. Naushad N. Tomy M. Sreelaksmi MS. Narmadha MP. Effect of Antenatal Betamethasone on Respiratory Distress Syndrome in Preterm Neonates. Research Journal of Pharmacy and Technology. 2022; 15(4): 1533-1536. doi: 10.52711/0974-360X.2022.00255
17. Shree J. Daniel CJ. Marsh C. Daniel JS. Lavanya S. A Study on Continuous Infusion versus Intermittent bolus dosing of Furosemide in Hospitalized Heart failure patients. Research Journal of Pharmacy and Technology. 2021; 14(5): 2814-2818. doi: 10.52711/0974-360X.2021.00496